BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Women's health
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, November 18, 2024
Breaking News: Healing a health divide (that’s long overdue)
See today's BioWorld Science
Home
» LY6E and TCN2, new diagnostic biomarkers and therapeutic targets for RSV infection
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Biomarkers
LY6E and TCN2, new diagnostic biomarkers and therapeutic targets for RSV infection
Oct. 7, 2024
No Comments
Investigators at Wuxi No. 2 Peoples Hospital and affiliated organizations conducted studies to identify novel effective biomarkers for early-stage pediatric respiratory syncytial virus (RSV) infection (EPR).
BioWorld Science
Biomarkers
Infection
Respiratory
